Genmab A/S Cash Flow Statement Analysis

Operating, investing, and financing activities in billions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Genmab A/S (GMAB) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income7.845.640.780.450.782.861.61
Depreciation & Amortization0.410.300.050.030.040.140.09
Stock Based Compensation0.720.090.060.050.030.000.00
Change in Working Capital-1.601.36-0.26-0.110.16-1.22-0.63
Change in Accounts Receivable-1.590.12-0.31-0.150.050.000.00
Change in Inventory0.00-0.010.000.000.000.000.00
Change in Accounts Payable0.000.090.040.050.030.000.00
Change in Other Working Capital0.00-0.14-0.04-0.030.000.000.00
Other Operating Activities0.390.59-0.17-0.190.180.01-0.23
Net Cash from Operating Activities7.777.380.560.341.061.331.02
Investing Activities
Capital Expenditures-0.190.38-0.05-0.04-0.05-0.08-0.07
Acquisitions-12.250.000.000.000.000.000.00
Purchases of Investments-8.64-0.13-0.35-0.11-0.340.000.00
Sales/Maturities of Investments11.28-0.91-2.44-0.71-2.04-1.87-1.30
Other Investing Activities-0.120.000.000.000.000.000.00
Net Cash from Investing Activities-9.91-1.28-0.40-0.15-0.39-1.98-1.78
Financing Activities
Debt Repayment-0.06-0.09-0.07-0.06-0.04-0.030.00
Common Stock Issued0.00-0.560.040.020.023.87-0.15
Common Stock Repurchased-3.99-0.10-0.14-0.080.000.000.00
Other Financing Activities0.13-0.10-0.09-0.05-0.03-0.250.00
Net Cash from Financing Activities-3.92-0.61-0.11-0.060.013.66-0.07
Summary
Effect of Forex Changes on Cash1.05-0.520.570.85-0.450.020.02
Net Change in Cash-5.015.490.130.260.613.00-0.83
Cash at Beginning of Period14.879.898.967.263.550.531.35
Cash at End of Period9.8614.879.898.967.263.550.53
Free Cash Flow7.587.000.520.301.011.220.54
Supplemental Disclosures
Interest Paid0.000.000.000.000.000.000.00
Income Taxes Paid0.050.160.230.110.240.000.00